Related Experiment Videos
The fine points of end points: phase II trials in lung cancer
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2022
ESO-ESMO fifth international consensus guidelines for breast cancer in young women (BCY5).
Annals of oncology : official journal of the European Society for Medical Oncology·2022
ESO-ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4).
Annals of oncology : official journal of the European Society for Medical Oncology·2020
Adjuvant pembrolizumab for the treatment of clear cell renal cell carcinoma: Five-year results from the phase III KEYNOTE-564 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Thymic Radiation is Associated with Worse Outcomes in Patients with NSCLC.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2- -associated high-risk HER2-negative early breast cancer: Updated results from the OlympiA phase III trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Five-Year Outcomes of Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer From the Randomized KEYNOTE-671 Study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Atezolizumab with or without tiragolumab in unresectable esophageal squamous cell carcinoma following definitive concurrent chemoradiotherapy (SKYSCRAPER-07): a randomised, phase III study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER).
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Postoperative infection risk factors in lung cancer patients after bronchoalveolar lavage.
Journal of thoracic disease·2026
Bronchoalveolar lavage fluid EGFR genotyping during bronchoscopic biopsy: concordance with tissue and additional molecular diagnostic yield in lung cancer.
Translational lung cancer research·2026
[Usefulness of Lipiodol Lymphangiography and Computed Tomography in Surgical Management of Chylothorax After Thoracic Aortic Surgery].
Kyobu geka. The Japanese journal of thoracic surgery·2026